Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period
about
Prophylactic intravenous antifungal agents to prevent mortality and morbidity in very low birth weight infantsIn vitro activity of A-192411.29, a novel antifungal lipopeptideIn vitro activity of BMS-181184 compared with those of fluconazole and amphotericin B against various candida sppMultiple efflux mechanisms are involved in Candida albicans fluconazole resistanceNew and emerging yeast pathogensBloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998.The ins and outs of DNA fingerprinting the infectious fungiHospital specificity, region specificity, and fluconazole resistance of Candida albicans bloodstream isolatesClinical evaluation of the ASTY colorimetric microdilution panel for antifungal susceptibility testing.Constant low rate of fungemia in norway, 1991 to 1996. The Norwegian Yeast Study Group.Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003.Potential role of phospholipases in virulence and fungal pathogenesis.One year prospective survey of Candida bloodstream infections in Scotland.Rapid identification of up to three Candida species in a single reaction tube by a 5' exonuclease assay using fluorescent DNA probes.Trends in antifungal use and epidemiology of nosocomial yeast infections in a university hospital.Comparison of the API Candida system with the AUXACOLOR system for identification of common yeast pathogens.Rapid identification of fungi by using the ITS2 genetic region and an automated fluorescent capillary electrophoresis system.Fluconazole susceptibilities of bloodstream Candida sp. isolates as determined by National Committee for Clinical Laboratory Standards method M27-A and two other methodsIdentification and phylogenetic relationship of the most common pathogenic Candida species inferred from mitochondrial cytochrome b gene sequencesOutbreak of Pichia anomala infection in the pediatric service of a tertiary-care center in Northern India.Rapid identification of yeasts in positive blood cultures by a multiplex PCR method.In vitro and in vivo antifungal activities of TAK-456, a novel oral triazole with a broad antifungal spectrum.Fatal endocarditis in a neonate caused by the dematiaceous fungus Phialemonium obovatum: case report and review of the literature.Vaginal yeasts in the era of "over the counter" antifungalsIn vitro antifungal susceptibility testing.Antifungal resistance among Candida species.Therapeutic dilemma of fluconazole prophylaxis in intensive care.Assessing risk factors for systemic fungal infections.Use of CHROMagar Candida for the presumptive identification of Candida species directly from clinical specimens in resource-limited settingsAntifungal drug resistance.Resistance of Candida species to fluconazoleAntifungal susceptibility testing of yeasts: evaluation of technical variables for test automation.Demonstration of synergy with fluconazole and either ibuprofen, sodium salicylate, or propylparaben against Candida albicans in vitroSusceptibilities of Candida spp. to antifungal agents visualized by two-dimensional scatterplots of relative growthMicrodilution antifungal susceptibility testing of Candida albicans and Cryptococcus neoformans with and without agitation: an eight-center collaborative studyIsolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemiaNo increase in frequency of antifungal resistance among yeasts isolated from normally sterile sites in patients at Foothills Hospital from 1993 to 1996.Comparison of visual and spectrophotometric methods of MIC endpoint determinations by using broth microdilution methods to test five antifungal agents, including the new triazole D0870.Torulopsis glabrata: azole susceptibilities by microdilution colorimetric and macrodilution broth assays
P2860
Q24247461-8D4B25CC-9D29-4AF4-907E-D29F86E56C87Q28344147-ADF6CC49-7828-469B-B579-2F1B24B8AEBDQ28379251-C79FB7B7-A0B4-4C2F-B2F2-B690EC8E2A00Q28379619-D51C2886-E9FC-480C-940C-2073C83393CEQ30452880-0EA94914-85E8-465C-9979-351F9B1457BEQ30453663-8132EE1E-6733-493D-881F-DE3F2DDF85D2Q33555593-ABBFFB00-0A57-4F69-8923-228ACA9F2FBEQ33668650-F36758C8-390C-46A7-B270-5515CEAC2C06Q33682650-F817EC9B-860E-4C18-9527-52914D8C5972Q33684486-2F14646B-07F8-4D42-84E7-3E3876E78C7AQ33721804-D8161631-593B-4890-83F6-5E6FFF5C2E0AQ33753405-F040928B-76A5-44E4-BFC7-02577385E593Q33812431-CF54F03A-B093-4C1B-9B46-D019C04F7ACAQ33910250-B482A63C-BFBD-428D-8A43-A6E7535D9967Q33958156-6F3AF91B-4C2E-4E49-9525-47F786F36AF7Q33959121-11EE3DD0-CFA4-4525-8426-3B89A071D0BAQ33959438-95EA83DA-1621-4767-A94C-10CDD908F8C4Q33960875-1FB08A47-7695-4BA8-9929-D55510419ADEQ33961413-4584CF75-A5F1-4FA8-968B-4517213F9105Q33970604-76454D44-FBB3-4416-91E5-4B5ECACD0751Q33972156-11CB44ED-6DE8-4F93-AAB8-5D677513D0C7Q33973560-22C96700-ED44-4283-B717-2F289B686555Q34106775-7D328135-A95C-4480-A551-8F661A34340EQ34130815-CBE606A9-3D82-48FB-98C0-33E9F02B44D0Q34163636-A8C82CAC-4CD2-4F3B-AB7B-8621EAA1A4D8Q34335217-25C5669B-56ED-465B-A0DE-F1DCA1F8A8AEQ34335225-10279A04-42A8-4F4F-A0AB-6BEB3EEFF80EQ34509391-36A382AD-8A40-458D-8C52-43B40E2A8035Q34517136-F57155AE-1724-4AA0-A35B-55DF3CF0F29FQ34764156-C6F8C990-FA5E-4CE4-BE1B-22DF189B1ACCQ35040008-E89F1705-9CA4-467D-847D-C13CA33164F8Q35110522-C69871E8-EE7A-4372-A9A0-BD3436B96D1AQ35118435-FC1A0AB7-DA68-4E27-96D7-348D886C4286Q35120560-93F4AF08-2EE6-486E-A1B3-4DE3C91FBE94Q35122897-C87A96F1-291D-4934-904C-2A7D01FAA901Q35128351-63A4D93C-D810-4515-99F3-88D4BEB2F01DQ35131728-EAFF5B4E-664B-4AF2-9233-F0FAD85296DBQ35649719-E570FFC0-48FC-4D55-A96F-27AEDCE9B55AQ36521532-84536BB7-99F8-41DA-860D-EE0B3886FA02Q36525340-D3942FF4-C354-4BA4-A151-DB99C63A00A0
P2860
Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Fluconazole susceptibilities o ...... cultures over a 5-year period
@ast
Fluconazole susceptibilities o ...... cultures over a 5-year period
@en
type
label
Fluconazole susceptibilities o ...... cultures over a 5-year period
@ast
Fluconazole susceptibilities o ...... cultures over a 5-year period
@en
prefLabel
Fluconazole susceptibilities o ...... cultures over a 5-year period
@ast
Fluconazole susceptibilities o ...... cultures over a 5-year period
@en
P2093
P2860
P356
P1476
Fluconazole susceptibilities o ...... cultures over a 5-year period
@en
P2093
P2860
P304
P356
10.1128/AAC.38.6.1422
P407
P577
1994-06-01T00:00:00Z